Svitinib 12.5mg Capsule is a targeted therapy medication used in the treatment of certain types of cancer. Its active ingredient is Sunitinib, a potent tyrosine kinase inhibitor. Sunitinib works by blocking the activity of specific enzymes (tyrosine kinases) that are crucial for the growth and proliferation of cancer cells. By inhibiting these enzymes, Sunitinib helps to slow down or stop the growth of tumors and can also inhibit the formation of new blood vessels that feed the tumor.
Svitinib is indicated for the treatment of advanced renal cell carcinoma (RCC), imatinib-resistant gastrointestinal stromal tumor (GIST), and advanced pancreatic neuroendocrine tumors (pNET). The typical dosage and administration will be determined by a healthcare professional based on the specific condition being treated and the patient’s response. It is usually taken orally once a day.
Common side effects may include fatigue, diarrhea, nausea, vomiting, hair color changes, and hypertension. More serious side effects can occur, and patients should report any unusual or severe symptoms to their doctor immediately. Svitinib should be stored at room temperature, away from moisture and heat, and out of reach of children.
